nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—HTR1B—obesity	0.306	1	CbGaD
Naratriptan—MAOA—Phentermine—obesity	0.165	0.363	CbGbCtD
Naratriptan—MAOA—Phenylpropanolamine—obesity	0.157	0.347	CbGbCtD
Naratriptan—MAOA—Methamphetamine—obesity	0.132	0.29	CbGbCtD
Naratriptan—Almotriptan—HTR1B—obesity	0.000625	0.248	CrCbGaD
Naratriptan—Sumatriptan—HTR1B—obesity	0.000601	0.239	CrCbGaD
Naratriptan—Eletriptan—HTR1B—obesity	0.000487	0.193	CrCbGaD
Naratriptan—Sumatriptan—DRD2—obesity	0.000404	0.16	CrCbGaD
Naratriptan—Almotriptan—CYP2E1—obesity	0.000404	0.16	CrCbGaD
Naratriptan—Immune system disorder—Orlistat—obesity	0.000176	0.00128	CcSEcCtD
Naratriptan—Tinnitus—Sibutramine—obesity	0.000175	0.00128	CcSEcCtD
Naratriptan—Sweating—Bupropion—obesity	0.000175	0.00128	CcSEcCtD
Naratriptan—Sleep disorder—Topiramate—obesity	0.000174	0.00127	CcSEcCtD
Naratriptan—Dizziness—Diethylpropion—obesity	0.000174	0.00127	CcSEcCtD
Naratriptan—Polyuria—Topiramate—obesity	0.000172	0.00126	CcSEcCtD
Naratriptan—Alopecia—Orlistat—obesity	0.000172	0.00125	CcSEcCtD
Naratriptan—Sinusitis—Bupropion—obesity	0.000171	0.00125	CcSEcCtD
Naratriptan—Diarrhoea—Cimetidine—obesity	0.000171	0.00125	CcSEcCtD
Naratriptan—Angiopathy—Sibutramine—obesity	0.000171	0.00125	CcSEcCtD
Naratriptan—Gastroenteritis—Topiramate—obesity	0.00017	0.00124	CcSEcCtD
Naratriptan—Immune system disorder—Sibutramine—obesity	0.00017	0.00124	CcSEcCtD
Naratriptan—Vascular purpura—Topiramate—obesity	0.000169	0.00123	CcSEcCtD
Naratriptan—Chills—Sibutramine—obesity	0.000169	0.00123	CcSEcCtD
Naratriptan—Arrhythmia—Sibutramine—obesity	0.000168	0.00123	CcSEcCtD
Naratriptan—Eye pain—Topiramate—obesity	0.000167	0.00122	CcSEcCtD
Naratriptan—Vomiting—Diethylpropion—obesity	0.000167	0.00122	CcSEcCtD
Naratriptan—Alopecia—Sibutramine—obesity	0.000166	0.00121	CcSEcCtD
Naratriptan—Rash—Diethylpropion—obesity	0.000166	0.00121	CcSEcCtD
Naratriptan—Dermatitis—Diethylpropion—obesity	0.000166	0.00121	CcSEcCtD
Naratriptan—Dizziness—Cimetidine—obesity	0.000165	0.00121	CcSEcCtD
Naratriptan—Haemoglobin—Bupropion—obesity	0.000165	0.0012	CcSEcCtD
Naratriptan—Headache—Diethylpropion—obesity	0.000165	0.0012	CcSEcCtD
Naratriptan—Haemorrhage—Bupropion—obesity	0.000164	0.0012	CcSEcCtD
Naratriptan—Hypoaesthesia—Bupropion—obesity	0.000163	0.00119	CcSEcCtD
Naratriptan—Hallucination—Bupropion—obesity	0.000163	0.00119	CcSEcCtD
Naratriptan—Libido decreased—Topiramate—obesity	0.000163	0.00119	CcSEcCtD
Naratriptan—Muscle spasms—Orlistat—obesity	0.000163	0.00119	CcSEcCtD
Naratriptan—Vision blurred—Orlistat—obesity	0.000159	0.00116	CcSEcCtD
Naratriptan—Vomiting—Cimetidine—obesity	0.000159	0.00116	CcSEcCtD
Naratriptan—Thirst—Topiramate—obesity	0.000159	0.00116	CcSEcCtD
Naratriptan—Rash—Cimetidine—obesity	0.000158	0.00115	CcSEcCtD
Naratriptan—Dermatitis—Cimetidine—obesity	0.000158	0.00115	CcSEcCtD
Naratriptan—Muscle spasms—Sibutramine—obesity	0.000157	0.00115	CcSEcCtD
Naratriptan—Ill-defined disorder—Orlistat—obesity	0.000157	0.00115	CcSEcCtD
Naratriptan—Headache—Cimetidine—obesity	0.000157	0.00114	CcSEcCtD
Naratriptan—Purpura—Topiramate—obesity	0.000157	0.00114	CcSEcCtD
Naratriptan—Nausea—Diethylpropion—obesity	0.000156	0.00114	CcSEcCtD
Naratriptan—Vision blurred—Sibutramine—obesity	0.000154	0.00113	CcSEcCtD
Naratriptan—Tremor—Sibutramine—obesity	0.000153	0.00112	CcSEcCtD
Naratriptan—Tinnitus—Bupropion—obesity	0.000153	0.00112	CcSEcCtD
Naratriptan—Malaise—Orlistat—obesity	0.000153	0.00111	CcSEcCtD
Naratriptan—Cardiac disorder—Bupropion—obesity	0.000152	0.00111	CcSEcCtD
Naratriptan—Vertigo—Orlistat—obesity	0.000152	0.00111	CcSEcCtD
Naratriptan—Ill-defined disorder—Sibutramine—obesity	0.000152	0.00111	CcSEcCtD
Naratriptan—Anaemia—Sibutramine—obesity	0.000151	0.0011	CcSEcCtD
Naratriptan—Agitation—Sibutramine—obesity	0.000151	0.0011	CcSEcCtD
Naratriptan—Disturbance in sexual arousal—Topiramate—obesity	0.00015	0.00109	CcSEcCtD
Naratriptan—Palpitations—Orlistat—obesity	0.00015	0.00109	CcSEcCtD
Naratriptan—Angiopathy—Bupropion—obesity	0.000149	0.00109	CcSEcCtD
Naratriptan—Migraine—Topiramate—obesity	0.000149	0.00109	CcSEcCtD
Naratriptan—Nausea—Cimetidine—obesity	0.000149	0.00108	CcSEcCtD
Naratriptan—Immune system disorder—Bupropion—obesity	0.000148	0.00108	CcSEcCtD
Naratriptan—Malaise—Sibutramine—obesity	0.000148	0.00108	CcSEcCtD
Naratriptan—Cough—Orlistat—obesity	0.000148	0.00108	CcSEcCtD
Naratriptan—Chills—Bupropion—obesity	0.000147	0.00107	CcSEcCtD
Naratriptan—Vertigo—Sibutramine—obesity	0.000147	0.00107	CcSEcCtD
Naratriptan—Syncope—Sibutramine—obesity	0.000147	0.00107	CcSEcCtD
Naratriptan—Convulsion—Orlistat—obesity	0.000147	0.00107	CcSEcCtD
Naratriptan—Arrhythmia—Bupropion—obesity	0.000147	0.00107	CcSEcCtD
Naratriptan—Alopecia—Bupropion—obesity	0.000145	0.00106	CcSEcCtD
Naratriptan—Palpitations—Sibutramine—obesity	0.000145	0.00106	CcSEcCtD
Naratriptan—Myalgia—Orlistat—obesity	0.000144	0.00105	CcSEcCtD
Naratriptan—Loss of consciousness—Sibutramine—obesity	0.000144	0.00105	CcSEcCtD
Naratriptan—Anxiety—Orlistat—obesity	0.000144	0.00105	CcSEcCtD
Naratriptan—Cough—Sibutramine—obesity	0.000143	0.00104	CcSEcCtD
Naratriptan—Discomfort—Orlistat—obesity	0.000142	0.00104	CcSEcCtD
Naratriptan—Convulsion—Sibutramine—obesity	0.000142	0.00104	CcSEcCtD
Naratriptan—Dry mouth—Orlistat—obesity	0.000141	0.00103	CcSEcCtD
Naratriptan—Dehydration—Topiramate—obesity	0.00014	0.00103	CcSEcCtD
Naratriptan—Liver function test abnormal—Topiramate—obesity	0.000139	0.00102	CcSEcCtD
Naratriptan—Arthralgia—Sibutramine—obesity	0.000139	0.00102	CcSEcCtD
Naratriptan—Myalgia—Sibutramine—obesity	0.000139	0.00102	CcSEcCtD
Naratriptan—Anxiety—Sibutramine—obesity	0.000139	0.00101	CcSEcCtD
Naratriptan—Anaphylactic shock—Orlistat—obesity	0.000138	0.00101	CcSEcCtD
Naratriptan—Oedema—Orlistat—obesity	0.000138	0.00101	CcSEcCtD
Naratriptan—Discomfort—Sibutramine—obesity	0.000138	0.00101	CcSEcCtD
Naratriptan—Muscle spasms—Bupropion—obesity	0.000137	0.001	CcSEcCtD
Naratriptan—Infection—Orlistat—obesity	0.000137	0.001	CcSEcCtD
Naratriptan—Dry mouth—Sibutramine—obesity	0.000136	0.000995	CcSEcCtD
Naratriptan—Nervous system disorder—Orlistat—obesity	0.000135	0.000989	CcSEcCtD
Naratriptan—Confusional state—Sibutramine—obesity	0.000135	0.000984	CcSEcCtD
Naratriptan—Vision blurred—Bupropion—obesity	0.000135	0.000982	CcSEcCtD
Naratriptan—Skin disorder—Orlistat—obesity	0.000134	0.000979	CcSEcCtD
Naratriptan—Tremor—Bupropion—obesity	0.000134	0.000976	CcSEcCtD
Naratriptan—Gastritis—Topiramate—obesity	0.000134	0.000976	CcSEcCtD
Naratriptan—Oedema—Sibutramine—obesity	0.000134	0.000976	CcSEcCtD
Naratriptan—Anaphylactic shock—Sibutramine—obesity	0.000134	0.000976	CcSEcCtD
Naratriptan—Hyperhidrosis—Orlistat—obesity	0.000134	0.000975	CcSEcCtD
Naratriptan—Infection—Sibutramine—obesity	0.000133	0.000969	CcSEcCtD
Naratriptan—Ill-defined disorder—Bupropion—obesity	0.000132	0.000967	CcSEcCtD
Naratriptan—Anaemia—Bupropion—obesity	0.000132	0.000963	CcSEcCtD
Naratriptan—Shock—Sibutramine—obesity	0.000132	0.00096	CcSEcCtD
Naratriptan—Agitation—Bupropion—obesity	0.000131	0.000958	CcSEcCtD
Naratriptan—Thrombocytopenia—Sibutramine—obesity	0.000131	0.000955	CcSEcCtD
Naratriptan—Asthma—Topiramate—obesity	0.000131	0.000953	CcSEcCtD
Naratriptan—Skin disorder—Sibutramine—obesity	0.00013	0.000948	CcSEcCtD
Naratriptan—Hyperhidrosis—Sibutramine—obesity	0.000129	0.000943	CcSEcCtD
Naratriptan—Malaise—Bupropion—obesity	0.000129	0.00094	CcSEcCtD
Naratriptan—Vertigo—Bupropion—obesity	0.000128	0.000936	CcSEcCtD
Naratriptan—Syncope—Bupropion—obesity	0.000128	0.000935	CcSEcCtD
Naratriptan—Angina pectoris—Topiramate—obesity	0.000127	0.000928	CcSEcCtD
Naratriptan—Palpitations—Bupropion—obesity	0.000126	0.000921	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Orlistat—obesity	0.000126	0.000918	CcSEcCtD
Naratriptan—Bronchitis—Topiramate—obesity	0.000126	0.000916	CcSEcCtD
Naratriptan—Loss of consciousness—Bupropion—obesity	0.000125	0.000916	CcSEcCtD
Naratriptan—Abdominal discomfort—Topiramate—obesity	0.000125	0.000914	CcSEcCtD
Naratriptan—Hypotension—Sibutramine—obesity	0.000125	0.000912	CcSEcCtD
Naratriptan—Cough—Bupropion—obesity	0.000125	0.000909	CcSEcCtD
Naratriptan—Paraesthesia—Orlistat—obesity	0.000124	0.000905	CcSEcCtD
Naratriptan—Convulsion—Bupropion—obesity	0.000124	0.000903	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Sibutramine—obesity	0.000122	0.000889	CcSEcCtD
Naratriptan—Myalgia—Bupropion—obesity	0.000122	0.000887	CcSEcCtD
Naratriptan—Arthralgia—Bupropion—obesity	0.000122	0.000887	CcSEcCtD
Naratriptan—Anxiety—Bupropion—obesity	0.000121	0.000884	CcSEcCtD
Naratriptan—Pollakiuria—Topiramate—obesity	0.000121	0.00088	CcSEcCtD
Naratriptan—Discomfort—Bupropion—obesity	0.00012	0.000877	CcSEcCtD
Naratriptan—Paraesthesia—Sibutramine—obesity	0.00012	0.000876	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Orlistat—obesity	0.000119	0.00087	CcSEcCtD
Naratriptan—Dyspnoea—Sibutramine—obesity	0.000119	0.00087	CcSEcCtD
Naratriptan—Photosensitivity reaction—Topiramate—obesity	0.000119	0.00087	CcSEcCtD
Naratriptan—Fatigue—Orlistat—obesity	0.000119	0.000869	CcSEcCtD
Naratriptan—Dry mouth—Bupropion—obesity	0.000119	0.000868	CcSEcCtD
Naratriptan—Somnolence—Sibutramine—obesity	0.000119	0.000867	CcSEcCtD
Naratriptan—Pain—Orlistat—obesity	0.000118	0.000862	CcSEcCtD
Naratriptan—Hyperglycaemia—Topiramate—obesity	0.000118	0.00086	CcSEcCtD
Naratriptan—Confusional state—Bupropion—obesity	0.000117	0.000858	CcSEcCtD
Naratriptan—Pneumonia—Topiramate—obesity	0.000117	0.000855	CcSEcCtD
Naratriptan—Oedema—Bupropion—obesity	0.000117	0.000851	CcSEcCtD
Naratriptan—Anaphylactic shock—Bupropion—obesity	0.000117	0.000851	CcSEcCtD
Naratriptan—Depression—Topiramate—obesity	0.000116	0.000847	CcSEcCtD
Naratriptan—Infection—Bupropion—obesity	0.000116	0.000845	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Sibutramine—obesity	0.000115	0.000842	CcSEcCtD
Naratriptan—Shock—Bupropion—obesity	0.000115	0.000837	CcSEcCtD
Naratriptan—Constipation—Sibutramine—obesity	0.000114	0.000834	CcSEcCtD
Naratriptan—Pain—Sibutramine—obesity	0.000114	0.000834	CcSEcCtD
Naratriptan—Nervous system disorder—Bupropion—obesity	0.000114	0.000834	CcSEcCtD
Naratriptan—Neuropathy peripheral—Topiramate—obesity	0.000114	0.000833	CcSEcCtD
Naratriptan—Thrombocytopenia—Bupropion—obesity	0.000114	0.000833	CcSEcCtD
Naratriptan—Feeling abnormal—Orlistat—obesity	0.000114	0.000831	CcSEcCtD
Naratriptan—Skin disorder—Bupropion—obesity	0.000113	0.000826	CcSEcCtD
Naratriptan—Hyperhidrosis—Bupropion—obesity	0.000113	0.000822	CcSEcCtD
Naratriptan—Feeling abnormal—Sibutramine—obesity	0.00011	0.000804	CcSEcCtD
Naratriptan—Urticaria—Orlistat—obesity	0.00011	0.000801	CcSEcCtD
Naratriptan—Sinusitis—Topiramate—obesity	0.000109	0.000797	CcSEcCtD
Naratriptan—Body temperature increased—Orlistat—obesity	0.000109	0.000797	CcSEcCtD
Naratriptan—Hypotension—Bupropion—obesity	0.000109	0.000795	CcSEcCtD
Naratriptan—Bradycardia—Topiramate—obesity	0.000106	0.000776	CcSEcCtD
Naratriptan—Urticaria—Sibutramine—obesity	0.000106	0.000775	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Bupropion—obesity	0.000106	0.000775	CcSEcCtD
Naratriptan—Body temperature increased—Sibutramine—obesity	0.000106	0.000771	CcSEcCtD
Naratriptan—Haemoglobin—Topiramate—obesity	0.000105	0.000767	CcSEcCtD
Naratriptan—Paraesthesia—Bupropion—obesity	0.000105	0.000764	CcSEcCtD
Naratriptan—Haemorrhage—Topiramate—obesity	0.000104	0.000763	CcSEcCtD
Naratriptan—Hypoaesthesia—Topiramate—obesity	0.000104	0.000759	CcSEcCtD
Naratriptan—Hallucination—Topiramate—obesity	0.000104	0.000759	CcSEcCtD
Naratriptan—Dyspnoea—Bupropion—obesity	0.000104	0.000758	CcSEcCtD
Naratriptan—Somnolence—Bupropion—obesity	0.000104	0.000756	CcSEcCtD
Naratriptan—Hypersensitivity—Orlistat—obesity	0.000102	0.000743	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Bupropion—obesity	0.000101	0.000734	CcSEcCtD
Naratriptan—Fatigue—Bupropion—obesity	0.0001	0.000733	CcSEcCtD
Naratriptan—Pain—Bupropion—obesity	9.96e-05	0.000727	CcSEcCtD
Naratriptan—Constipation—Bupropion—obesity	9.96e-05	0.000727	CcSEcCtD
Naratriptan—Asthenia—Orlistat—obesity	9.91e-05	0.000723	CcSEcCtD
Naratriptan—Hypersensitivity—Sibutramine—obesity	9.85e-05	0.000719	CcSEcCtD
Naratriptan—Pruritus—Orlistat—obesity	9.77e-05	0.000713	CcSEcCtD
Naratriptan—Tinnitus—Topiramate—obesity	9.74e-05	0.000711	CcSEcCtD
Naratriptan—Cardiac disorder—Topiramate—obesity	9.7e-05	0.000708	CcSEcCtD
Naratriptan—Feeling abnormal—Bupropion—obesity	9.6e-05	0.000701	CcSEcCtD
Naratriptan—Asthenia—Sibutramine—obesity	9.59e-05	0.0007	CcSEcCtD
Naratriptan—Angiopathy—Topiramate—obesity	9.48e-05	0.000692	CcSEcCtD
Naratriptan—Pruritus—Sibutramine—obesity	9.46e-05	0.00069	CcSEcCtD
Naratriptan—Diarrhoea—Orlistat—obesity	9.45e-05	0.00069	CcSEcCtD
Naratriptan—Immune system disorder—Topiramate—obesity	9.44e-05	0.000689	CcSEcCtD
Naratriptan—Chills—Topiramate—obesity	9.38e-05	0.000684	CcSEcCtD
Naratriptan—Urticaria—Bupropion—obesity	9.26e-05	0.000676	CcSEcCtD
Naratriptan—Alopecia—Topiramate—obesity	9.23e-05	0.000674	CcSEcCtD
Naratriptan—Body temperature increased—Bupropion—obesity	9.21e-05	0.000672	CcSEcCtD
Naratriptan—Diarrhoea—Sibutramine—obesity	9.15e-05	0.000668	CcSEcCtD
Naratriptan—Dizziness—Orlistat—obesity	9.13e-05	0.000667	CcSEcCtD
Naratriptan—Erythema—Topiramate—obesity	9.1e-05	0.000664	CcSEcCtD
Naratriptan—Dizziness—Sibutramine—obesity	8.84e-05	0.000645	CcSEcCtD
Naratriptan—Vomiting—Orlistat—obesity	8.78e-05	0.000641	CcSEcCtD
Naratriptan—Muscle spasms—Topiramate—obesity	8.75e-05	0.000638	CcSEcCtD
Naratriptan—Rash—Orlistat—obesity	8.71e-05	0.000636	CcSEcCtD
Naratriptan—Dermatitis—Orlistat—obesity	8.7e-05	0.000635	CcSEcCtD
Naratriptan—Headache—Orlistat—obesity	8.65e-05	0.000632	CcSEcCtD
Naratriptan—Hypersensitivity—Bupropion—obesity	8.59e-05	0.000627	CcSEcCtD
Naratriptan—Vision blurred—Topiramate—obesity	8.57e-05	0.000626	CcSEcCtD
Naratriptan—Tremor—Topiramate—obesity	8.52e-05	0.000622	CcSEcCtD
Naratriptan—Vomiting—Sibutramine—obesity	8.5e-05	0.00062	CcSEcCtD
Naratriptan—Ill-defined disorder—Topiramate—obesity	8.44e-05	0.000616	CcSEcCtD
Naratriptan—Rash—Sibutramine—obesity	8.43e-05	0.000615	CcSEcCtD
Naratriptan—Dermatitis—Sibutramine—obesity	8.42e-05	0.000615	CcSEcCtD
Naratriptan—Anaemia—Topiramate—obesity	8.41e-05	0.000614	CcSEcCtD
Naratriptan—Headache—Sibutramine—obesity	8.37e-05	0.000611	CcSEcCtD
Naratriptan—Asthenia—Bupropion—obesity	8.36e-05	0.00061	CcSEcCtD
Naratriptan—Agitation—Topiramate—obesity	8.36e-05	0.00061	CcSEcCtD
Naratriptan—Pruritus—Bupropion—obesity	8.24e-05	0.000602	CcSEcCtD
Naratriptan—Nausea—Orlistat—obesity	8.2e-05	0.000599	CcSEcCtD
Naratriptan—Malaise—Topiramate—obesity	8.2e-05	0.000599	CcSEcCtD
Naratriptan—Vertigo—Topiramate—obesity	8.17e-05	0.000597	CcSEcCtD
Naratriptan—Syncope—Topiramate—obesity	8.16e-05	0.000595	CcSEcCtD
Naratriptan—Palpitations—Topiramate—obesity	8.04e-05	0.000587	CcSEcCtD
Naratriptan—Loss of consciousness—Topiramate—obesity	7.99e-05	0.000584	CcSEcCtD
Naratriptan—Diarrhoea—Bupropion—obesity	7.97e-05	0.000582	CcSEcCtD
Naratriptan—Nausea—Sibutramine—obesity	7.94e-05	0.00058	CcSEcCtD
Naratriptan—Cough—Topiramate—obesity	7.94e-05	0.000579	CcSEcCtD
Naratriptan—Convulsion—Topiramate—obesity	7.88e-05	0.000575	CcSEcCtD
Naratriptan—Myalgia—Topiramate—obesity	7.74e-05	0.000565	CcSEcCtD
Naratriptan—Arthralgia—Topiramate—obesity	7.74e-05	0.000565	CcSEcCtD
Naratriptan—Anxiety—Topiramate—obesity	7.72e-05	0.000563	CcSEcCtD
Naratriptan—Dizziness—Bupropion—obesity	7.71e-05	0.000562	CcSEcCtD
Naratriptan—Discomfort—Topiramate—obesity	7.65e-05	0.000559	CcSEcCtD
Naratriptan—Dry mouth—Topiramate—obesity	7.57e-05	0.000553	CcSEcCtD
Naratriptan—Confusional state—Topiramate—obesity	7.49e-05	0.000546	CcSEcCtD
Naratriptan—Oedema—Topiramate—obesity	7.42e-05	0.000542	CcSEcCtD
Naratriptan—Vomiting—Bupropion—obesity	7.41e-05	0.000541	CcSEcCtD
Naratriptan—Infection—Topiramate—obesity	7.38e-05	0.000538	CcSEcCtD
Naratriptan—Rash—Bupropion—obesity	7.35e-05	0.000536	CcSEcCtD
Naratriptan—Dermatitis—Bupropion—obesity	7.34e-05	0.000536	CcSEcCtD
Naratriptan—Shock—Topiramate—obesity	7.3e-05	0.000533	CcSEcCtD
Naratriptan—Headache—Bupropion—obesity	7.3e-05	0.000533	CcSEcCtD
Naratriptan—Nervous system disorder—Topiramate—obesity	7.28e-05	0.000531	CcSEcCtD
Naratriptan—Thrombocytopenia—Topiramate—obesity	7.27e-05	0.000531	CcSEcCtD
Naratriptan—Skin disorder—Topiramate—obesity	7.21e-05	0.000526	CcSEcCtD
Naratriptan—Hyperhidrosis—Topiramate—obesity	7.18e-05	0.000524	CcSEcCtD
Naratriptan—Hypotension—Topiramate—obesity	6.94e-05	0.000506	CcSEcCtD
Naratriptan—Nausea—Bupropion—obesity	6.92e-05	0.000505	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Topiramate—obesity	6.76e-05	0.000494	CcSEcCtD
Naratriptan—Paraesthesia—Topiramate—obesity	6.67e-05	0.000487	CcSEcCtD
Naratriptan—Dyspnoea—Topiramate—obesity	6.62e-05	0.000483	CcSEcCtD
Naratriptan—Somnolence—Topiramate—obesity	6.6e-05	0.000482	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Topiramate—obesity	6.41e-05	0.000468	CcSEcCtD
Naratriptan—Fatigue—Topiramate—obesity	6.4e-05	0.000467	CcSEcCtD
Naratriptan—Constipation—Topiramate—obesity	6.35e-05	0.000463	CcSEcCtD
Naratriptan—Pain—Topiramate—obesity	6.35e-05	0.000463	CcSEcCtD
Naratriptan—Feeling abnormal—Topiramate—obesity	6.12e-05	0.000447	CcSEcCtD
Naratriptan—Urticaria—Topiramate—obesity	5.9e-05	0.00043	CcSEcCtD
Naratriptan—Body temperature increased—Topiramate—obesity	5.87e-05	0.000428	CcSEcCtD
Naratriptan—Hypersensitivity—Topiramate—obesity	5.47e-05	0.000399	CcSEcCtD
Naratriptan—Asthenia—Topiramate—obesity	5.33e-05	0.000389	CcSEcCtD
Naratriptan—Pruritus—Topiramate—obesity	5.25e-05	0.000383	CcSEcCtD
Naratriptan—Diarrhoea—Topiramate—obesity	5.08e-05	0.000371	CcSEcCtD
Naratriptan—HTR1A—hindbrain—obesity	5.01e-05	0.115	CbGeAlD
Naratriptan—Dizziness—Topiramate—obesity	4.91e-05	0.000358	CcSEcCtD
Naratriptan—Vomiting—Topiramate—obesity	4.72e-05	0.000345	CcSEcCtD
Naratriptan—Rash—Topiramate—obesity	4.68e-05	0.000342	CcSEcCtD
Naratriptan—Dermatitis—Topiramate—obesity	4.68e-05	0.000341	CcSEcCtD
Naratriptan—Headache—Topiramate—obesity	4.65e-05	0.000339	CcSEcCtD
Naratriptan—MAOA—hindbrain—obesity	4.57e-05	0.105	CbGeAlD
Naratriptan—Nausea—Topiramate—obesity	4.41e-05	0.000322	CcSEcCtD
Naratriptan—MAOA—islet of Langerhans—obesity	2.96e-05	0.0682	CbGeAlD
Naratriptan—HTR1B—cardiovascular system—obesity	2.9e-05	0.0669	CbGeAlD
Naratriptan—HTR1D—cardiovascular system—obesity	2.81e-05	0.0648	CbGeAlD
Naratriptan—MAOA—respiratory system—obesity	2.79e-05	0.0644	CbGeAlD
Naratriptan—MAOA—adrenal cortex—obesity	2.34e-05	0.0541	CbGeAlD
Naratriptan—HTR1A—cardiovascular system—obesity	2.34e-05	0.054	CbGeAlD
Naratriptan—MAOA—cardiovascular system—obesity	2.14e-05	0.0493	CbGeAlD
Naratriptan—HTR1B—endocrine gland—obesity	1.99e-05	0.0459	CbGeAlD
Naratriptan—MAOA—pituitary gland—obesity	1.89e-05	0.0437	CbGeAlD
Naratriptan—MAOA—adipose tissue—obesity	1.89e-05	0.0435	CbGeAlD
Naratriptan—HTR1A—adrenal gland—obesity	1.85e-05	0.0427	CbGeAlD
Naratriptan—MAOA—digestive system—obesity	1.78e-05	0.041	CbGeAlD
Naratriptan—MAOA—adrenal gland—obesity	1.69e-05	0.039	CbGeAlD
Naratriptan—HTR1A—endocrine gland—obesity	1.61e-05	0.037	CbGeAlD
Naratriptan—MAOA—endocrine gland—obesity	1.47e-05	0.0338	CbGeAlD
Naratriptan—MAOA—liver—obesity	1.32e-05	0.0305	CbGeAlD
Naratriptan—MAOA—Metabolism—GNAS—obesity	8.02e-06	7.99e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SOCS3—obesity	8.02e-06	7.99e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—INS—obesity	8.01e-06	7.97e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NPS—obesity	7.99e-06	7.96e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SOCS1—obesity	7.95e-06	7.92e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PIK3CD—obesity	7.88e-06	7.85e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCL2—obesity	7.88e-06	7.85e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—F2—obesity	7.86e-06	7.83e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PRKCB—obesity	7.86e-06	7.83e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOB—obesity	7.86e-06	7.83e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SOCS3—obesity	7.85e-06	7.82e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GNB3—obesity	7.85e-06	7.82e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DRD1—obesity	7.84e-06	7.81e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR2C—obesity	7.84e-06	7.81e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IGF1—obesity	7.74e-06	7.71e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—TYK2—obesity	7.74e-06	7.71e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—AKT2—obesity	7.74e-06	7.71e-05	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PIK3CB—obesity	7.72e-06	7.7e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AGT—obesity	7.72e-06	7.69e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF2—obesity	7.71e-06	7.68e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GNB3—obesity	7.69e-06	7.66e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—RHOA—obesity	7.68e-06	7.65e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—GNAS—obesity	7.65e-06	7.62e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NTRK2—obesity	7.62e-06	7.6e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PIK3R1—obesity	7.6e-06	7.57e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADRB1—obesity	7.59e-06	7.56e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—TYK2—obesity	7.58e-06	7.55e-05	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PIK3CB—obesity	7.56e-06	7.54e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF2—obesity	7.55e-06	7.52e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CG—obesity	7.52e-06	7.49e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—RHOA—obesity	7.52e-06	7.49e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—LPL—obesity	7.5e-06	7.47e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOB—obesity	7.49e-06	7.46e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—GNAS—obesity	7.49e-06	7.46e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PIK3R1—obesity	7.44e-06	7.41e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3CD—obesity	7.43e-06	7.41e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PARP1—obesity	7.43e-06	7.4e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GHRL—obesity	7.43e-06	7.4e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DRD4—obesity	7.37e-06	7.34e-05	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—PIK3CA—obesity	7.36e-06	7.34e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SERPINE1—obesity	7.35e-06	7.33e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOB—obesity	7.33e-06	7.3e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GPX1—obesity	7.32e-06	7.29e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL5—obesity	7.31e-06	7.28e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL5—obesity	7.16e-06	7.13e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—POMC—obesity	7.16e-06	7.13e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TYK2—obesity	7.15e-06	7.12e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—LPL—obesity	7.15e-06	7.12e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—F2—obesity	7.14e-06	7.11e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PRKCB—obesity	7.14e-06	7.11e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CD36—obesity	7.13e-06	7.1e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FOXO1—obesity	7.1e-06	7.07e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—RHOA—obesity	7.09e-06	7.07e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RPS6KB1—obesity	7.08e-06	7.06e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CNR1—obesity	7.04e-06	7.01e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3R1—obesity	7.02e-06	6.99e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NOS3—obesity	7.02e-06	6.99e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PIK3CB—obesity	7.01e-06	6.99e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—LPL—obesity	7e-06	6.97e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FOXO1—obesity	6.95e-06	6.92e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RPS6KB1—obesity	6.94e-06	6.91e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TCF7L2—obesity	6.91e-06	6.89e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AKT2—obesity	6.88e-06	6.85e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PIK3CB—obesity	6.87e-06	6.84e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DRD2—obesity	6.86e-06	6.84e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CG—obesity	6.83e-06	6.8e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GCG—obesity	6.8e-06	6.77e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTPN1—obesity	6.8e-06	6.77e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—MTHFR—obesity	6.75e-06	6.73e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—PIK3CA—obesity	6.69e-06	6.66e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PPARA—obesity	6.63e-06	6.6e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CD—obesity	6.61e-06	6.59e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PRKCD—obesity	6.59e-06	6.56e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—POMC—obesity	6.5e-06	6.48e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PRL—obesity	6.48e-06	6.46e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MTOR—obesity	6.48e-06	6.46e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3CB—obesity	6.48e-06	6.46e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PRKCD—obesity	6.45e-06	6.42e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HTR2A—obesity	6.45e-06	6.42e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—C3—obesity	6.44e-06	6.41e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—AGT—obesity	6.42e-06	6.39e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—STK11—obesity	6.39e-06	6.36e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL2—obesity	6.36e-06	6.34e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PLG—obesity	6.32e-06	6.29e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HTR2A—obesity	6.31e-06	6.29e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—RHOA—obesity	6.31e-06	6.28e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—C3—obesity	6.3e-06	6.28e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOE—obesity	6.29e-06	6.26e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AKT2—obesity	6.25e-06	6.22e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3R1—obesity	6.24e-06	6.22e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CAV1—obesity	6.23e-06	6.21e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—APOA1—obesity	6.22e-06	6.19e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FOXO3—obesity	6.17e-06	6.14e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ADRB2—obesity	6.15e-06	6.13e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IRS2—obesity	6.12e-06	6.1e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AGT—obesity	6.12e-06	6.09e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SOCS1—obesity	6.06e-06	6.03e-05	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—AKT1—obesity	6.02e-06	5.99e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CD—obesity	6e-06	5.98e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IRS2—obesity	6e-06	5.97e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOE—obesity	5.99e-06	5.97e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—LEP—obesity	5.99e-06	5.97e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AGT—obesity	5.99e-06	5.97e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SOCS3—obesity	5.98e-06	5.96e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CAV1—obesity	5.94e-06	5.91e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APOA1—obesity	5.92e-06	5.9e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL6—obesity	5.92e-06	5.9e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—LEP—obesity	5.87e-06	5.85e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOE—obesity	5.87e-06	5.85e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GNB3—obesity	5.86e-06	5.83e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CAV1—obesity	5.81e-06	5.79e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APOA1—obesity	5.8e-06	5.78e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—TYK2—obesity	5.77e-06	5.75e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CB—obesity	5.76e-06	5.74e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF2—obesity	5.75e-06	5.73e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—RHOA—obesity	5.73e-06	5.71e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ESR1—obesity	5.72e-06	5.7e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—GNAS—obesity	5.7e-06	5.68e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CG—obesity	5.68e-06	5.65e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3R1—obesity	5.67e-06	5.65e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—F2—obesity	5.65e-06	5.63e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PRKCB—obesity	5.65e-06	5.63e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MMP9—obesity	5.63e-06	5.61e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ESR1—obesity	5.6e-06	5.58e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOB—obesity	5.58e-06	5.56e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—BAD—obesity	5.58e-06	5.56e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PRKCB—obesity	5.53e-06	5.51e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—F2—obesity	5.53e-06	5.51e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MAPK8—obesity	5.48e-06	5.46e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PPARG—obesity	5.48e-06	5.46e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—BAD—obesity	5.47e-06	5.45e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—AKT1—obesity	5.46e-06	5.44e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL5—obesity	5.45e-06	5.43e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CG—obesity	5.41e-06	5.39e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—POMC—obesity	5.4e-06	5.38e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—INS—obesity	5.37e-06	5.35e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IRS1—obesity	5.35e-06	5.33e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LPL—obesity	5.33e-06	5.31e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CG—obesity	5.3e-06	5.28e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FOXO1—obesity	5.29e-06	5.27e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RPS6KB1—obesity	5.28e-06	5.26e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IRS1—obesity	5.23e-06	5.21e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CB—obesity	5.23e-06	5.21e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—POMC—obesity	5.15e-06	5.13e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—INS—obesity	5.12e-06	5.1e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—POMC—obesity	5.04e-06	5.02e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL2—obesity	5.04e-06	5.02e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—INS—obesity	5.01e-06	4.99e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—STAT3—obesity	5.01e-06	4.99e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CD—obesity	4.99e-06	4.97e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IGF1—obesity	4.95e-06	4.93e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AKT2—obesity	4.95e-06	4.93e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL2—obesity	4.93e-06	4.91e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—ALB—obesity	4.92e-06	4.91e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PRKCD—obesity	4.91e-06	4.89e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IGF1—obesity	4.85e-06	4.83e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AKT2—obesity	4.84e-06	4.83e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HTR2A—obesity	4.81e-06	4.79e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—C3—obesity	4.8e-06	4.78e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CD—obesity	4.75e-06	4.74e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3R1—obesity	4.71e-06	4.69e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—NOS3—obesity	4.71e-06	4.69e-05	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PIK3CA—obesity	4.71e-06	4.69e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SERPINE1—obesity	4.7e-06	4.68e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CD—obesity	4.66e-06	4.64e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MYC—obesity	4.65e-06	4.64e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TGFB1—obesity	4.64e-06	4.62e-05	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PIK3CA—obesity	4.61e-06	4.59e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SERPINE1—obesity	4.6e-06	4.59e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TYK2—obesity	4.57e-06	4.56e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IRS2—obesity	4.57e-06	4.55e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AGT—obesity	4.56e-06	4.54e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RHOA—obesity	4.54e-06	4.52e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3R1—obesity	4.49e-06	4.47e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOS3—obesity	4.49e-06	4.47e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TYK2—obesity	4.48e-06	4.46e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOE—obesity	4.47e-06	4.45e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—LEP—obesity	4.47e-06	4.45e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RHOA—obesity	4.44e-06	4.42e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CAV1—obesity	4.43e-06	4.41e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APOA1—obesity	4.42e-06	4.4e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3R1—obesity	4.4e-06	4.38e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOS3—obesity	4.4e-06	4.38e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CB—obesity	4.35e-06	4.33e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTGS2—obesity	4.31e-06	4.29e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PIK3CA—obesity	4.28e-06	4.26e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ESR1—obesity	4.27e-06	4.25e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—F2—obesity	4.22e-06	4.2e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PRKCB—obesity	4.22e-06	4.2e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PIK3CA—obesity	4.19e-06	4.17e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—BAD—obesity	4.17e-06	4.15e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CB—obesity	4.14e-06	4.13e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MTOR—obesity	4.14e-06	4.13e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CB—obesity	4.06e-06	4.04e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MTOR—obesity	4.06e-06	4.04e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CG—obesity	4.03e-06	4.02e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IRS1—obesity	3.99e-06	3.97e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3CA—obesity	3.95e-06	3.94e-05	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—AKT1—obesity	3.85e-06	3.83e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—POMC—obesity	3.84e-06	3.83e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—INS—obesity	3.82e-06	3.8e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL6—obesity	3.79e-06	3.77e-05	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—AKT1—obesity	3.77e-06	3.75e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL2—obesity	3.76e-06	3.74e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL6—obesity	3.71e-06	3.69e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IGF1—obesity	3.69e-06	3.68e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AKT2—obesity	3.69e-06	3.68e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MMP9—obesity	3.6e-06	3.59e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CD—obesity	3.55e-06	3.53e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MMP9—obesity	3.53e-06	3.51e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CA—obesity	3.51e-06	3.5e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SERPINE1—obesity	3.51e-06	3.49e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MAPK8—obesity	3.5e-06	3.49e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL6—obesity	3.5e-06	3.48e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—AKT1—obesity	3.49e-06	3.48e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MAPK8—obesity	3.43e-06	3.42e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—AKT1—obesity	3.42e-06	3.41e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TYK2—obesity	3.41e-06	3.4e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RHOA—obesity	3.38e-06	3.37e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3R1—obesity	3.35e-06	3.34e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOS3—obesity	3.35e-06	3.34e-05	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—AKT1—obesity	3.23e-06	3.21e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—STAT3—obesity	3.2e-06	3.19e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CA—obesity	3.19e-06	3.18e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—STAT3—obesity	3.14e-06	3.12e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CB—obesity	3.09e-06	3.08e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MTOR—obesity	3.09e-06	3.08e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MYC—obesity	2.98e-06	2.96e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TGFB1—obesity	2.97e-06	2.96e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MYC—obesity	2.91e-06	2.9e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TGFB1—obesity	2.91e-06	2.9e-05	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AKT1—obesity	2.87e-06	2.86e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL6—obesity	2.82e-06	2.81e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MMP9—obesity	2.69e-06	2.68e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CA—obesity	2.65e-06	2.64e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MAPK8—obesity	2.61e-06	2.6e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AKT1—obesity	2.61e-06	2.6e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CA—obesity	2.53e-06	2.52e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CA—obesity	2.47e-06	2.46e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—STAT3—obesity	2.39e-06	2.38e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL6—obesity	2.24e-06	2.23e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MYC—obesity	2.22e-06	2.21e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TGFB1—obesity	2.21e-06	2.21e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL6—obesity	2.19e-06	2.18e-05	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—AKT1—obesity	2.17e-06	2.16e-05	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AKT1—obesity	2.06e-06	2.06e-05	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AKT1—obesity	2.02e-06	2.01e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CA—obesity	1.88e-06	1.88e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL6—obesity	1.67e-06	1.66e-05	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AKT1—obesity	1.54e-06	1.53e-05	CbGpPWpGaD
